JANUX THERAPEUTICS INC (JANX)

US47103J1051 - Common Stock

50.82  -6.99 (-12.09%)

After market: 50.84 +0.02 (+0.04%)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-9-30)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
13.05M8.08M8.61M3.64M0.00
Operating Expenses
99.01M81.06M75.70M36.57M4.84M
Research and Development
59.82M54.92M53.44M26.24M3.04M
Selling, General, and Administrative Expenses
39.19M26.14M22.26M10.33M1.80M
Operating Income
-85.96M-72.98M-67.09M-32.93M-4.84M
Interest Income/Expense
25.43M14.69M4.03M260.00K-1.94M
Income Before Taxes
-60.54M-58.29M-63.06M-32.67M-6.78M
Net Income
-60.54M-58.29M-63.06M-32.67M-6.78M
EBITDA
-83.88M-71.02M-66.25M-32.82M-4.83M
 
Per Share Data
EPS Diluted Total Ops
-1.18-1.32-1.52-0.78-0.17
Non GAAP EPS
-1.17-1.34-1.52N/AN/A
 
Statistics
Profit Margin
-463.91%-721.18%-732.40%-897.53%N/A
Operating Profit Margin
-658.76%-902.87%-779.21%-904.67%N/A

All data in USD

Charts